Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,151,028 papers from all fields of science
Search
Sign In
Create Free Account
GUCY2F gene
Known as:
GUANYLATE CYCLASE 2F, RETINAL
, RetGC-2
, GUC2DL
Expand
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Inferring Novel Tumor Suppressor Genes with a Protein-Protein Interaction Network and Network Diffusion Algorithms
Lei Chen
,
Yu-Hang Zhang
,
Zhenghua Zhang
,
Tao Huang
,
Yu-Dong Cai
Molecular Therapy: Methods & Clinical Development
2018
Corpus ID: 51889420
2016
2016
Functional Study and Mapping Sites for Interaction with the Target Enzyme in Retinal Degeneration 3 (RD3) Protein *
I. Peshenko
,
E. Olshevskaya
,
A. Dizhoor
Journal of Biological Chemistry
2016
Corpus ID: 25440252
Retinal degeneration 3 (RD3) protein, essential for normal expression of retinal membrane guanylyl cyclase (RetGC) in…
Expand
2012
2012
Retinal Guanylyl Cyclase Isozyme 1 Is the Preferential In Vivo Target for Constitutively Active GCAP1 Mutants Causing Congenital Degeneration of Photoreceptors
E. Olshevskaya
,
I. Peshenko
,
A. Savchenko
,
A. Dizhoor
Journal of Neuroscience
2012
Corpus ID: 9242434
Two calcium-sensitive guanylyl cyclase activating proteins (GCAP1 and GCAP2) activate cGMP synthesis in photoreceptor by retinal…
Expand
2012
2012
Gucy2f zebrafish knockdown – a model for Gucy2d-related leber congenital amaurosis
H. Stiebel-Kalish
,
Ehud Reich
,
+5 authors
M. Bach
European Journal of Human Genetics
2012
Corpus ID: 24548670
Mutations in retinal-specific guanylate cyclase (Gucy2d) are associated with Leber congenital amaurosis-1 (LCA1). Zebrafish offer…
Expand
Review
2009
Review
2009
Novel functions of photoreceptor guanylate cyclases revealed by targeted deletion
Sukanya Karan
,
J. Frederick
,
W. Baehr
Molecular and Cellular Biochemistry
2009
Corpus ID: 42141894
Targeted deletion of membrane guanylate cyclases (GCs) has yielded new information concerning their function. Here, we summarize…
Expand
Highly Cited
2008
Highly Cited
2008
A Role for GCAP2 in Regulating the Photoresponse
C. Makino
,
I. Peshenko
,
Xiao-Hong Wen
,
E. Olshevskaya
,
Ronald Barrett
,
A. Dizhoor
Journal of Biological Chemistry
2008
Corpus ID: 4640139
Cyclic GMP serves as the second messenger in visual transduction, linking photon absorption by rhodopsin to the activity of ion…
Expand
Highly Cited
2006
Highly Cited
2006
Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers
L. Wood
,
E. Calhoun
,
+12 authors
V. Velculescu
Human Mutation
2006
Corpus ID: 34046523
Tyrosine kinases are major regulators of signal transduction cascades involved in cellular proliferation and have important roles…
Expand
Review
1999
Review
1999
Regulation of photoreceptor membrane guanylyl cyclases by guanylyl cyclase activator proteins.
A. Dizhoor
,
J. Hurley
Methods
1999
Corpus ID: 20908377
Guanylyl cyclase (GC) plays a central role in the responses of vertebrate rod and cone photoreceptors to light. cGMP is an…
Expand
Highly Cited
1998
Highly Cited
1998
The kinase homology domain of retinal guanylyl cyclases 1 and 2 specifies the affinity and cooperativity of interaction with guanylyl cyclase activating protein-2.
R. Laura
,
J. Hurley
Biochemistry
1998
Corpus ID: 24108338
RetGC-1 and RetGC-2 are photoreceptor membrane guanylyl cyclases that are regulated by the Ca2+-binding protein, GCAP-2. We used…
Expand
Highly Cited
1995
Highly Cited
1995
Cloning and expression of a second photoreceptor-specific membrane retina guanylyl cyclase (RetGC), RetGC-2.
D. Lowe
,
A. Dizhoor
,
+5 authors
J. Hurley
Proceedings of the National Academy of Sciences…
1995
Corpus ID: 24907976
One of the membrane guanylyl cyclases (GCs), RetGC, is expressed predominantly in photoreceptors. No extracellular ligand has…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE